Phosphate disorders are common in patients with cancer. Hypophosphatemia and hyperphosphatemia, both, can lead to significant morbidity, and their mechanisms are uniquely influenced by tumor biology, anti-cancer therapies, and cellular shifts. Malignancies tha... ...
